Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.
2.

Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection.

Ahmed SS, Santosh W, Kumar S, Christlet HT.

J Biomed Sci. 2009 Jul 13;16:63. doi: 10.1186/1423-0127-16-63.

3.

Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson's disease in Indian population.

Sanyal J, Ahmed SS, Ng HK, Naiya T, Ghosh E, Banerjee TK, Lakshmi J, Guha G, Rao VR.

Sci Rep. 2016 Oct 18;6:35097. doi: 10.1038/srep35097.

4.

Serum trace element levels and the complexity of inter-element relations in patients with Parkinson's disease.

Hegde ML, Shanmugavelu P, Vengamma B, Rao TS, Menon RB, Rao RV, Rao KS.

J Trace Elem Med Biol. 2004;18(2):163-71.

PMID:
15646263
5.

Association of Parkinson's disease with altered serum levels of lead and transition metals among South Indian subjects.

Kumudini N, Uma A, Devi YP, Naushad SM, Mridula R, Borgohain R, Kutala VK.

Indian J Biochem Biophys. 2014 Apr;51(2):121-6.

PMID:
24980015
6.

Serum copper, zinc and selenium levels in Tunisian patients with Parkinson's disease.

Younes-Mhenni S, Aissi M, Mokni N, Boughammoura-Bouatay A, Chebel S, Frih-Ayed M, Kerkeni A, Bost M, Chazot G, Sfar MT, Sfar MH.

Tunis Med. 2013 Jun;91(6):402-5.

7.
8.

Species fractionation in a case-control study concerning Parkinson's disease: Cu-amino acids discriminate CSF of PD from controls.

Willkommen D, Lucio M, Schmitt-Kopplin P, Gazzaz M, Schroeter M, Sigaroudi A, Michalke B.

J Trace Elem Med Biol. 2018 Sep;49:164-170. doi: 10.1016/j.jtemb.2018.01.005. Epub 2018 Feb 20.

PMID:
29472131
9.

Serum vitamins and heavy metals in blood and urine, and the correlations among them in Parkinson's disease patients in China.

Fukushima T, Tan X, Luo Y, Kanda H.

Neuroepidemiology. 2011;36(4):240-4. doi: 10.1159/000328253. Epub 2011 Jun 16.

PMID:
21677448
10.

Bioinformatics analysis raises candidate genes in blood for early screening of Parkinson's disease.

Zhang Y, Yao L, Liu W, Li W, Tian C, Wang ZY, Liu D.

Biomed Environ Sci. 2014 Jun;27(6):462-5. doi: 10.3967/bes2014.074.

11.

Biomarkers of Parkinson's disease: present and future.

Miller DB, O'Callaghan JP.

Metabolism. 2015 Mar;64(3 Suppl 1):S40-6. doi: 10.1016/j.metabol.2014.10.030. Epub 2014 Oct 31. Review.

12.

Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease.

Picillo M, Santangelo G, Moccia M, Erro R, Amboni M, Prestipino E, Longo K, Vitale C, Spina E, Orefice G, Barone P, Pellecchia MT.

J Neural Transm (Vienna). 2016 Apr;123(4):371-7. doi: 10.1007/s00702-015-1502-5. Epub 2016 Jan 6.

PMID:
26739446
13.

Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease.

Trezzi JP, Galozzi S, Jaeger C, Barkovits K, Brockmann K, Maetzler W, Berg D, Marcus K, Betsou F, Hiller K, Mollenhauer B.

Mov Disord. 2017 Oct;32(10):1401-1408. doi: 10.1002/mds.27132. Epub 2017 Aug 26.

PMID:
28843022
14.

microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.

Leggio L, Vivarelli S, L'Episcopo F, Tirolo C, Caniglia S, Testa N, Marchetti B, Iraci N.

Int J Mol Sci. 2017 Dec 13;18(12). pii: E2698. doi: 10.3390/ijms18122698. Review.

15.

Found in transcription: accurate Parkinson's disease classification in peripheral blood.

Karlsson MK, Sharma P, Aasly J, Toft M, Skogar O, Sæbø S, Lönneborg A.

J Parkinsons Dis. 2013;3(1):19-29. doi: 10.3233/JPD-120159.

PMID:
23938308
16.

Serum miR-221 serves as a biomarker for Parkinson's disease.

Ma W, Li Y, Wang C, Xu F, Wang M, Liu Y.

Cell Biochem Funct. 2016 Oct;34(7):511-515. doi: 10.1002/cbf.3224.

PMID:
27748571
17.

Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.

Luan H, Liu LF, Tang Z, Zhang M, Chua KK, Song JX, Mok VC, Li M, Cai Z.

Sci Rep. 2015 Sep 14;5:13888. doi: 10.1038/srep13888.

18.

Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.

Santiago JA, Potashkin JA.

PLoS One. 2015 Nov 13;10(11):e0142582. doi: 10.1371/journal.pone.0142582. eCollection 2015.

19.

COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.

Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group.

BMC Neurol. 2016 Feb 25;16:26. doi: 10.1186/s12883-016-0548-9. Erratum in: BMC Neurol. 2016;16:44.

20.

Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson's disease.

Zhao HW, Lin J, Wang XB, Cheng X, Wang JY, Hu BL, Zhang Y, Zhang X, Zhu JH.

PLoS One. 2013 Dec 10;8(12):e83060. doi: 10.1371/journal.pone.0083060. eCollection 2013.

Supplemental Content

Support Center